The concentrations of cortisol and testosterone (total and apparent free) in peripheral venous plasma were measured in 147 women. The results showed that there were no significant differences in concentrations between women with normal breasts, those with histologically confirmed benign or malignant breast tumours and those with cancer at other sites. There was, however, a significant increase with age in the concentrations of total (P < 0'005) and apparent free (P <002) cortisol.
Introduction
The physiological role of androgenic steroids in women is obscure. The most potent androgen secreted by the ovary and adrenal cortex is testo- sterone, but it is present in peripheral venous plasma in much lower concentrations than the weaker androgens, dehydroepiandrosterone sulphate, de- hydroepiandrosterone and androstenedione, which are mainly secreted by the adrenals. Previous studies have reported that abnormalities in androgen production and excretion are involved i i'ht~hihology and clinical course. of-breast c:crrif¥ (l ook et al., 1962; Ttiomaset al., 1976) .Bti "I$lation of testosterone metabolism in these patients has proved unrewarding (Jones, Ramsay and Collins, 1977b; Jones et al., 1977c) .
It has been shown in women that breast tumour tissue is more active than other tissues in metabolizing testosterone to another active compound, 5 o-dihydrotestosterone (Sa-DHT) (Forchelli et al., 1967) . The formation of 5a-DHT is greatest in the most undifferentiated cancers but does not occur in normal breast tissue (Jenkins and Ash, 1972) . Thus, breast tumours are a target organ for circulating testosterone although the mechanism of action of this hormone is not understood (Wagner and Jungblut, 1976) .
Many patients with breast cancer have impaired glucose tolerance and obesity. Furthermore, the prevalence of diabetes mellitus is increased. These metabolic abnormalities may precede the development of clinical malignancy (Glicksman and Rawson, 1956 ), and it has been suggested that these findings could be associated with an abnormal corticosteroid metabolism (Bell, Bulbrook and Desphande, 1967) . Elevated levels of circulating corticosteroids have been reported in patients with breast cancer (Desphande, Hayward and Bulbrook, 1965) and, as cortisol may suppress the cellular immune response in clinical and experimental situations (Fauci, 1976) , it is possible that high levels of this steroid may facilitate tumour development and growth.
The results from earlier work have indicated an association between abnormalities in androgen and corticosteroid metabolism in breast cancer (Bulbrook et al., 1962; Bulbrook, Hayward and Spicer, 1971) . Other investigators have suggested that the bulk of the circulating hormone which is strongly bound to plasma is biologically inert and only the unbound fraction is active (Rosenfield, 1971; Burke and Anderson, 1972 (Wise, York Mason and Ackerman, 1971) .) All gave their informed consent. The women were then categorized as being premenopausal, early postmenopausal (one to 10 years after the last menstrual period) and late postmenopausal (11 to 30 years after the last menstrual period). The postmenopausal group, were sub-divided as age-related changes in postmenopausal hormone concentrations have been demonstrated (Chakravarti et al., 1976) .
Blood sampling was performed between 10.30 and 12.00 a.m., as there is evidence of a diurnal rhythm in the levels of circulating testosterone and cortisol (Tyler, Newton and Collins, 1975 (Tyler et,al., 1975) . All patients on drugs likely to affect the concentrations of testosterone and cortisol in plasma were excluded from study.
Plasma testosterone was measured in a liquid phase radio-immunoassay system comprising tritiated testosterone as labelled antigen, and an antiserum raised against testosterone-3-carboxy-methyloxime-bovine serum albumin. After equilibration, dextran-coated charcoal was used to separate the antibody bound fraction (Tyler et al., 1973) . Under these conditions the cross-reaction with 5a-DHT was less than 15% and the inter-assay variation was within 12%.
Cortisol was determined by a similar liquid phase radioimmunoassay system comprising a tritiated antigen and antiserum raised in rabbits against cortisol-21-succinyl-bovine serum albumin.
Equilibrium dialysis was the technique chosen to separate the protein bound and unbound hormone.
The apparatus used was similar to that previously described (Ellis and Elkins, 1975) and consisted of a stoppered Teflon cell which was divided into 2 compartments by visking tubing. An aliquot (one ml) of the plasma sample was placed in the upper section and 5 ml of hepes buffer (pH 7-4) in the lower compartment. The cells were then incubated with continuous agitation at 37°C in a water bath.
Initially, experiments were carried out to ascertain the time necessary for dialysis. A plasma pool was collected from blood samples taken from normal menstruating women. A series of cells was then set up using aliquots of plasma from the pool. These were incubated over a 24-hr period with cells removed in duplicate at intervals. An 18-hr period of incubation was then chosen for subsequent studies.
For the estimations of cortisol the dialysate and plasma were extracted in ether and measured directly by radioimmunoassay. However, because of the smaller amounts of testosterone present in the samples, it was necessary to measure these indirectly by a radioactive tracer technique. After incubation and extraction as before, the fractions were dried and redissolved in buffer and the radioactivity counted. The total hormone concentration was estimated by radio-immunoassay and the amount of unbound hormone was then calculated using the Intra-assay (%) 8-9 9-4 Inter-assay (%)
21-6 23-6 Intra-assay (%)
Inter-assay (%/) 17-3 20-4
Results
The frequency with which the concentration of each hormone appeared was studied and it was concluded that the distribution was best described by the arithmetic mean and range.
Testosterone
The concentrations of apparent free and total plasma testosterone are shown in Figs. 1 Fig. 1 ). The groups are divided into premenopausal and 2 postmenopausal sub-groups. The means in each group are indicated by a dotted line.
Discussion
The concentrations of apparent free and total cortisol showed a statistically significant^increase with age. The effect of age has previously been investigated in healthy subjects and total plasma cortisol was reported to be well maintained (Bliss et aL., 1953) . It is stated that the concentration of urinary metabolites of cortisol, i.e. 17-oxogenic steroids, decline in later life-the discrepancy between the plasma and urinary steroids being explained by a reduced rate of degradation of cortisol (West et aL, 1961) . The biological significance of the finding of a small increase in cortisol with advancing age is difficult to evaluate. The total and apparent free plasma testosterone concentrations were well maintained after the menopause and showed no decline with advancing age, which is in agreement with an earlier study (Chakravarti et al., 1976 . . sterone with breast cancer (Bulbrook et al., 1962 (Bulbrook et al., , 1971 Thomas et al., 1976) . There were no significant differences in the concentrations of apparent free and total plasma cortisol between the various groups studied. Circulating cortisol is in dynamic equilibrium with at least 2 groups of plasma protein: (i) albumin and (ii) transcortin. In pregnancy, the total concentration increases as the protein-bound fraction rises but the free concentration remains constant and there are no clinical signs of hyperandrenocorticism. The in vitro activity of cortisol correlates with the nonprotein bound concentration of the steroid and is probably the main factor determining the extent of cortisol action on cellular function. These findings would seem to be in agreement with a previous study (Bell et al., 1967) which found no significant difference in the binding activity of transcortin or in the 'mean per cent. bound'. However, the authors cannot support the conclusion that women with breast cancer have more freely available cortisol; and their results differ from those of another group who found an increase in the carrier protein in the subjects studied (Sandberg, Slaunwhite and Carter, 1960) . Women with breast cancer have been variously reported as having abnormally high levels of plasma 17-hydroxycorticosteroids but normal urinary 17-hydroxycorticosteroids (Desphande et al., 1965) or normal plasma and low urinary concentrations (Beck et al., 1966) . These discrepancies cannot be explained by an abnormality in the protein bound component as suggested, and the authors have found no obvious difference in cortisol metabolism in these patients. The data agree with earlier studies measuring plasma cortisol (Jones et al., 1977a) and urinary free cortisol in similar groups of patients (Rose et al., 1977) .
The epidemiological evidence that hormones are involved in the development of breast cancer is strong (MacMahon, Cole and Brown, 1973) . However, studies on the plasma concentrations of hormones have generally not shown differences in those compounds known to be necessary for mammary growth and development (Swain, 1973; England et al., 1974; Jones et al., 1977a 
